Trump administration authorises 172 million barrel SPR drawdown as 32 IEA nations coordinate record emergency oil release
Read More 5 minute read Pharma Industry News Is GPCR immuno-oncology ready for prime time as Kainova Therapeutics advances DT-7012 Explore how Kainova Therapeutics’ DT-7012 program could reshape GPCR immuno-oncology and what it signals for investors and competitors. bySoujanya RaviFebruary 14, 2026